Compare Edwards Lifesciences Corporation Common Stock (EW) vs HubSpot Inc (HUBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs HubSpot Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while HubSpot Inc trades at $230.8 (market cap $10.98B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 4.5× HubSpot Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, HubSpot Inc nearer its low. Which is the better fit depends on your goals.
| EW | HUBS | |
|---|---|---|
Market Cap | $49.44B | $10.98B |
Volume | 3,508,027 | 1,027,893 |
Sector | Health | Technology |
52-Week High | $95.18 | $494.58 |
52-Week Low | $72.65 | $170.39 |
Enterprise Value | $45.90B | $9.88B |
Typical Hold Time | — | 78 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HubSpot (HUBS) trades at $231.84, up 6.86% in the past 24 hours, with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth from $1.7B in 2022 to $3.1B in 2025, with net income turning positive in 2024. Recent analyst day highlighted AI strategy enhancements and margin expansion targets through 2030, while technical indicators show resistance near $232 with RSI suggesting potential overbought conditions.
HUBS presents a mixed outlook with strong fundamental growth offset by high valuation multiples (P/E 78.39) and technical resistance. The consensus price target of $243.65 offers modest upside, supported by 59.6% analyst buy ratings, but risks include competitive pressures in CRM software and execution challenges in AI integration. Cash flow growth and institutional accumulation provide support for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About HubSpot Inc
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
Read more on HUBS →
